News
Everyone faces unique obstacles when it comes to weight loss. Some roadblocks stem from past experiences with weight ...
If you're among the half of US adults who have tried to lose weight in the last 12 months, you'll be aware of how enthusiasm ...
A weight loss plateau occurs when your weight stops changing despite continued efforts in diet and exercise.
A once-weekly dose of tirzepatide (Mounjaro) can lead to significant, sustained weight loss for up to 3 years in adults with ...
Clinically-backed thermogenic fat burners accelerate metabolism, ignite fat loss, and curb appetite—PhenQ leads 2025’s top ...
Medical Xpress on MSN11d
Tirzepatide produces clinically meaningful weight loss for at least 3 years in non-diabetic overweight adults: TrialThe associations between participants' groups and characteristics at the start of the study as well as weight-loss plateau ...
7d
Verywell Health on MSNZepbound Helps Keep Weight Off for 3 Years, Study FindsA pair of studies show that Zepbound can help adults with obesity and overweight achieve sustained and meaningful weight loss ...
Long-term use of tirzepatide shows sustained and significant weight loss in adults with overweight or obesity.
A daily weight loss pill being tested by Eli Lilly could work as well as its GLP-1 injection counterparts like Ozempic, ...
Diabetics given the pill called orforglipron lost 16 pounds, or 7.9% of their body weight, over a 40-week period.
Results that may be inaccessible to you are currently showing.
Hide inaccessible results